Skip to content
E213 - Metabolic dysfunction–associated fatty liver disease an update episode artwork

Apr 27, 2026 15 min

E213 - Metabolic dysfunction–associated fatty liver disease an update

from Australian Prescriber Podcast

Laura Beaton talks to hepatology research fellow Richard O'Halloran about his paper on metabolic dysfunction–associated fatty liver disease (MAFLD). Richard outlines risk factors and comorbidities to consider, and diagnostic tests for MAFLD. The conversation also covers management of MAFLD through risk stratification, addressing health risk behaviours, and surveillance. Read the full article in Australian Prescriber.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

E213 - Metabolic dysfunction–associated fatty liver disease an update

0:00 15:54

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Australian Prescriber Podcast?

This episode is 15 minutes long.

When was this Australian Prescriber Podcast episode published?

This episode was published on April 27, 2026.

Can I download this Australian Prescriber Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.